{
  "docId": "019de074-7a94-707c-b002-278357aaec02",
  "docSlug": "fb2ab974265a0e95c40d5a8a75128cd1",
  "documentTitle": "BenevolentAI | Results Presentation Deck | 38 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 38,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Includes clinical trial timeline and strategic intent for partnership.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-7a94-707c-b002-278357aaec02/18",
  "deckHref": "/decks/019de074-7a94-707c-b002-278357aaec02",
  "deckJsonHref": "/decks/019de074-7a94-707c-b002-278357aaec02.json",
  "deckAnchorHref": "/decks/019de074-7a94-707c-b002-278357aaec02#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.68
      },
      "kind": "callout",
      "text": "Our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and, if approved, commercialisation",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d270d95-f6ba-4f32-8aaf-a3025409773b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Phase IIa clinical study design timeline",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "085fe7f1-2f3a-4bd9-bc32-3ee99de3a7a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.08,
        "y": 0.68
      },
      "kind": "list",
      "text": "Current Status: LPLV achieved Jan 2023, 91 patients randomised, DBL completed 1st March, TLR anticipated end March",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a10f9b57-4c4c-4582-a75e-9e898f2c6439",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "LPLV - last patient last visit | DBL - database lock | TLR - Top line results",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f6bc070-85f2-454c-9d0f-0292fae632e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "BEN-2293 - Phase IIa study recruitment completed",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71511264-019c-4ed4-8936-9c99b95cbd3d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "1eb983e8-cad7-417d-851e-3f7c7dc616dd",
      "evidence": "Visual representation of clinical trial phases over time",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 18,
      "from": 16,
      "beatId": "822e78e8-50fd-475a-bfd8-2fe75d826127",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The section on BEN-2293 for Atopic Dermatitis presents a solution to the problem.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 16,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "05a47cba-105a-42ab-85c9-7caabd763d6d",
      "evidence": "The section on BEN-2293 presents a potential quick win.",
      "position": 1,
      "objective": "Can BEN-2293 provide a quick win in Atopic Dermatitis?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}